Remove Drug Development Remove Health Information Remove Industry
article thumbnail

Patients and Industry: Starting Our New Life Together in 2023

Society for Participatory Medicine

By the power vested in clinical research, the FDA now pronounces us patient and industry. The FDA issued a series of four patient-focused drug development (PFDD) guidance documents which outline how patient co-design needs to successfully happen. I’m here to deliver some great news: we tied the knot!

BioTech 112
article thumbnail

Health Consumers Are Now Amazon-Primed for Healthcare – HealthConsuming Explains, Part 2

Health Populi

In the past couple of months, Amazon announced many health-related plans and developments, including: Accepting medical and health savings accounts (HSAs) to pay for consumer health products like over-the-counter drugs. See more on that recommendation, and subsequent social media frenzy, here on Health Populi ).

HIPAA 307
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The 4 Big Gaps in HealthTech: Funding, Trust, Evidence, Valuation

Lloyd Price

Exec Summary: The healthtech industry, while brimming with potential, faces several significant challenges that hinder its full potential. Regulatory Hurdles: The stringent regulatory environment in healthcare can increase development costs and delay time to market, making it less attractive to investors.

article thumbnail

Future HealthTech Valuations in 2025: A Dynamic Landscape

Lloyd Price

However, based on current trends and industry insights, several areas are poised for significant growth and increased valuations: 1. Companies specialising in AI-driven medical imaging, drug development, and predictive analytics are likely to see substantial valuation increases.

article thumbnail

Pharma IT and AI – 2024 Health IT Predictions

Healthcare IT Today

The excitement around new tools took hold of all industries in 2023, and the potential is expansive. The unification of technology, services and pharmacovigilance expertise in the coming year will further enunciate the industry’s focus on patient safety. Dave Latshaw, CEO at BioPhy 1.

article thumbnail

Blockchain in Healthcare: A Vehicle Towards Digital Health 2.0?

The Digital Health Corner

Herding a patient’s data from many sources into a single record has always been a lofty goal of digital health. According to an excellent whitepaper describing a case study of Medrec , a platform utilizing blockchain technology, health information interoperability is facilitated with the use of blockchain.

article thumbnail

B2C2B models gaining traction in HealthTech

Lloyd Price

Data Privacy and Security: Ensuring the privacy and security of consumer data is crucial, especially when dealing with sensitive health information. Data-Driven Insights: B2C2B models generate a wealth of data that can be leveraged to refine products, identify new opportunities, and inform business decisions.